Rule, Simon
AstraZeneca,
Canada
2024 Rank: 121997
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2311 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 121997 | 120503 |
| Total Cites | 814 | 928 |
| H-index | 15 | 17 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 67 | 76 |
| Number of Single+First+Last Authored Papers | 93 | 93 |
| Total Cites to Single+First+Last Authored Papers | 221 | 244 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 531 | 568 |
| Ratio of Total Citations to Distinct Citing Papers | 1.53 | 1.63 |
| Self-Citation Percentage |
12.28%
|
|
Rule, Simon
University of Plymouth,
United Kingdom
2023 Rank: 68782
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1535 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 68782 | 63483 |
| Total Cites | 970 | 1127 |
| H-index | 17 | 19 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 95 | 112 |
| Number of Single+First+Last Authored Papers | 93 | 93 |
| Total Cites to Single+First+Last Authored Papers | 297 | 329 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 558 | 607 |
| Ratio of Total Citations to Distinct Citing Papers | 1.74 | 1.86 |
| Self-Citation Percentage |
13.93%
|
|
Rule, Simon
Derriford Hospital,
United Kingdom
2022 Rank: 80311
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1927 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 80311 | 79225 |
| Total Cites | 856 | 1051 |
| H-index | 16 | 17 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 72 | 85 |
| Number of Single+First+Last Authored Papers | 92 | 92 |
| Total Cites to Single+First+Last Authored Papers | 202 | 239 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 571 | 658 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.60 |
| Self-Citation Percentage |
18.55%
|
|
Rule, Simon
University of Plymouth,
United Kingdom
2021 Rank: 70743
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1591 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70743 | 66235 |
| Total Cites | 1272 | 1544 |
| H-index | 19 | 21 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 12 | 12 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 118 | 143 |
| Number of Single+First+Last Authored Papers | 87 | 87 |
| Total Cites to Single+First+Last Authored Papers | 315 | 377 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 796 | 904 |
| Ratio of Total Citations to Distinct Citing Papers | 1.60 | 1.71 |
| Self-Citation Percentage |
17.62%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.